Agios Pharmaceuticals, Inc.
AGIO
$29.45
$0.190.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -110.18% | 1,086.20% | -17.87% | 15.00% | -5.05% |
| Total Depreciation and Amortization | 1.64% | -15.57% | 18.18% | -3.92% | -13.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.76% | -9,234.12% | 26.74% | -43.35% | -46.52% |
| Change in Net Operating Assets | -202.00% | 347.93% | 134.93% | -617.59% | 307.25% |
| Cash from Operations | -58.12% | -16.02% | 27.31% | -37.77% | -17.59% |
| Capital Expenditure | -130.79% | -165.19% | -12.06% | 39.74% | 36.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | -194.10% | 36.92% | -70.00% | 30.20% | 148.47% |
| Cash from Investing | -119.60% | 573.38% | -70.10% | 30.41% | 142.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 83.62% | 139.95% | -81.26% | 592.33% | -54.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 83.62% | 139.95% | -81.26% | 592.33% | -54.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -204.89% | 594.11% | -212.07% | 28.01% | 216.90% |